21 results on '"Moore, R. D."'
Search Results
2. THE RESPONSE OF THE HISTIOCYTES AND MACROPHAGES IN THE LUNGS OF RABBITS INJECTED WITH FREUND'S ADJUVANT.
- Author
-
MOORE RD and SCHOENBERG MD
- Subjects
- Animals, Rabbits, Antigen-Antibody Reactions, Freund's Adjuvant, Granuloma, Histiocytes, Lung, Macrophages, Mycobacterium, Pathology, Pharmacology, Pulmonary Alveoli, Research, Skin Tests
- Published
- 1964
3. CELLULAR SITES OF SYNTHESIS OF RABBIT IMMUNOGLOBULINS DURING PRIMARY RESPONSE TO DIPTHERIA TOXOID-FREUND'S ADJUVANT.
- Author
-
SCHOENBERG MD, STAVITSKY AB, MOORE RD, and FREEMAN MJ
- Subjects
- Animals, Rabbits, Antibodies, Antibody Formation, Antigens, Diphtheria Toxoid, Fluorescence, Fluorescent Antibody Technique, Freund's Adjuvant, Immunoglobulin G, Immunoglobulin M, Immunoglobulins, Microscopy, Microscopy, Fluorescence, Monocytes, Mycobacterium Infections, Plasma Cells, Proteins metabolism, Research, Spleen, Tissue Culture Techniques, gamma-Globulins
- Abstract
The present studies are based on previous observations that the intravenous injection of diphtheria toxoid and complete Freund's adjuvant into rabbits resulted in an increased proliferation of cells associated with antibody synthesis; an accelerated, enhanced, and prolonged synthesis of antibody; and a lengthened interval between the appearance of gammaM- and gammaG-hemagglutinating antibodies in the circulation. The molecular species of antibodies that were synthesized by fragments of the spleens were determined by the incorporation of labeled amino acid into antibody and by binding of radioactive antigen by antibody. These studies were paralleled by determination of the presence and type of antibody within the cell by immunofluorescence. Evidence was obtained that non-phagocytic mononuclear cells in the walls of the sinusoids of the red pulp of the spleen are a major source of 19S gammaM-antibody and plasma cells in the non-follicular white pulp are a major source of gammaG-antibody. The data did not exclude the synthesis of gammaG-antibodies by the mononuclear cells, the synthesis of gammaM-antibodies by the plasma cells, or the synthesis of both antibodies by an occasional cell of either morphology. It was hypothesized that the 19S and 7S antibody responses evolved independently with the development of at least two different cell types, a mononuclear cell with capacity for 19S immunoglobulin synthesis and a plasma cell with capacity for 7S immunoglobulin synthesis.
- Published
- 1965
- Full Text
- View/download PDF
4. CONTRACTION OF THE RABBIT MAMMARY STRIP IN VITRO IN RESPONSE TO OXYTOCIN.
- Author
-
MOORE RD and ZARROW MX
- Subjects
- Animals, Female, Humans, In Vitro Techniques, Pregnancy, Rabbits, Acetylcholine, Atropine, Breast Feeding, Lactation, Mammary Glands, Animal, Oxytocin, Pharmacology, Pregnancy, Animal, Research
- Published
- 1965
- Full Text
- View/download PDF
5. ALVEOLAR LINING CELLS AND PULMONARY RETICULOENDOTHELIAL SYSTEM OF THE RABBIT.
- Author
-
MOORE RD and SCHOENBERG MD
- Subjects
- Animals, Rabbits, Electrons, Epithelium, Freund's Adjuvant, Histiocytes, Hyperplasia, Lung Diseases, Macrophages, Microscopy, Microscopy, Electron, Monocytes, Mononuclear Phagocyte System, Pathology, Phagocytosis, Pharmacology, Pulmonary Alveoli, Research, Toxicology
- Published
- 1964
6. CYTOPLASMIC INTERACTION BETWEEN MACROPHAGES AND LYMPHOCYTIC CELLS IN ANTIBODY SYNTHESIS.
- Author
-
SCHOENBERG MD, MUMAW VR, MOORE RD, and WEISBERGER AS
- Subjects
- Animals, Rabbits, Antibodies, Antibody Formation, Blood Cell Count, Cytoplasm, Immunization, Lymph Nodes, Lymphocytes, Macrophages, Research, Spleen
- Abstract
A direct cytoplasmic connection between macrophages and potential antibody-producing cells has been demonstrated in lymph nodes and spleen. This was observed in the tissues from both immunized and nonimmunized rabbits.
- Published
- 1964
- Full Text
- View/download PDF
7. THE CONFORMATION OF HYALURONIC ACID AND CHONDROITIN SULFATE C: THE METACHROMATIC REACTION.
- Author
-
SCHOENBERG MD and MOORE RD
- Subjects
- Humans, Chemical Phenomena, Chemistry, Chondroitin, Chondroitin Sulfates, Coloring Agents, Hyaluronic Acid, Phenothiazines, Research, Spectrophotometry, Sulfates, Umbilical Cord
- Published
- 1964
- Full Text
- View/download PDF
8. ORIGIN OF PLASMA CELLS IN SITES OF INFLAMMATION.
- Author
-
MOORE RD and SCHOENBERG MD
- Subjects
- Animals, Rabbits, Freund's Adjuvant, Histology, Immunization, Inflammation, Lung, Lymphocytes, Plasma Cells, Pulmonary Alveoli, Research, Toxicology, Vaccination
- Published
- 1964
- Full Text
- View/download PDF
9. THE CELLULAR RESPONSE OF THE SPLEEN AND ITS RELATIONSHIP TO THE CIRCULATING 19S AND 7S ANTIBODY IN THE ANTIGENICALLY STIMULATED RABBIT.
- Author
-
SCHOENBERG MD, RUPP JC, and MOORE RD
- Subjects
- Animals, Rabbits, Antibodies, Antibody Formation, Antigen-Antibody Reactions, Basophils, Diphtheria Toxoid, Freund's Adjuvant, Immunoglobulins, Lymphocytes, Mycobacterium, Plasma Cells, Research, Serum Globulins, Spleen
- Published
- 1964
10. CHANGES IN ANTIBODY PRODUCING CELLS IN THE SPLEEN DURING THE PRIMARY RESPONSE.
- Author
-
MOORE RD, MUMAW VR, and SCHOENBERG MD
- Subjects
- Animals, Rabbits, Antibody Formation, Antibody-Producing Cells, Diphtheria Toxoid, Electrons, Freund's Adjuvant, Immunoglobulin G, Immunoglobulin M, Microscopy, Microscopy, Electron, Monocytes, Mycobacterium, Pathology, Plasma Cells, Research, Spleen, Toxicology, gamma-Globulins
- Published
- 1965
- Full Text
- View/download PDF
11. Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era.
- Author
-
Ma, J., Luu, B., Ruderman, S. A., Whitney, B. M., Merrill, J. O., Mixson, L. S., Nance, R. M., Drumright, L. N., Hahn, A. W., Fredericksen, R. J., Chander, G., Lau, B., McCaul, M. E., Safren, S., O'Cleirigh, C., Cropsey, K., Mayer, K. H., Mathews, W. C., Moore, R. D., and Napravnik, S.
- Subjects
CLINICAL drug trials ,HIV infection transmission ,SUBSTANCE abuse ,PATIENT compliance ,SELF-evaluation ,STATISTICAL models ,ANTIRETROVIRAL agents ,METHAMPHETAMINE ,ACADEMIC medical centers ,VIRAL load ,RESEARCH funding ,MULTIPLE regression analysis ,QUESTIONNAIRES ,VISUAL analog scale ,CD4 lymphocyte count ,SEVERITY of illness index ,HIV infections ,MULTIVARIATE analysis ,DESCRIPTIVE statistics ,RELATIVE medical risk ,PSYCHOLOGY of HIV-positive persons ,HEROIN ,MEN who have sex with men ,RESEARCH ,CANNABIS (Genus) ,ALCOHOLISM ,INDIVIDUALIZED medicine ,HEALTH outcome assessment ,COMPARATIVE studies ,DISEASE susceptibility ,INFECTIOUS disease transmission ,CONFIDENCE intervals ,DRUGS of abuse ,CRACK cocaine ,REGRESSION analysis ,EVALUATION ,DISEASE risk factors ,ADULTS - Abstract
Substance use in people with HIV (PWH) negatively impacts antiretroviral therapy (ART) adherence. However, less is known about this in the current treatment era and the impact of specific substances or severity of substance use. We examined the associations of alcohol, marijuana, and illicit drug use (methamphetamine/crystal, cocaine/crack, illicit opioids/heroin) and their severity of use with adherence using multivariable linear regression in adult PWH in care between 2016 and 2020 at 8 sites across the US. PWH completed assessments of alcohol use severity (AUDIT-C), drug use severity (modified ASSIST), and ART adherence (visual analogue scale). Among 9400 PWH, 16% reported current hazardous alcohol use, 31% current marijuana use, and 15% current use of ≥1 illicit drugs. In multivariable analysis, current methamphetamine/crystal use, particularly common among men who had sex with men, was associated with 10.1% lower mean ART adherence (p < 0.001) and 2.6% lower adherence per 5-point higher severity of use (ASSIST score) (p < 0.001). Current and more severe use of alcohol, marijuana, and other illicit drugs were also associated with lower adherence in a dose-dependent manner. In the current HIV treatment era, individualized substance use treatment, especially for methamphetamine/crystal, and ART adherence should be prioritized. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
- Author
-
Sulkowski, M S, Thomas, D L, Chaisson, R E, and Moore, R D
- Subjects
HIV infection complications ,AMINOTRANSFERASES ,COMBINATION drug therapy ,COMPARATIVE studies ,HEPATITIS ,HIV infections ,HYPERBILIRUBINEMIA ,RESEARCH methodology ,MEDICAL cooperation ,NONPARAMETRIC statistics ,RESEARCH ,EVALUATION research ,RELATIVE medical risk ,ANTI-HIV agents ,CHRONIC hepatitis B ,CHRONIC hepatitis C ,DISEASE complications - Abstract
Context: Use of antiretroviral drugs, including protease inhibitors, for treatment of human immunodeficiency virus (HIV) infection has been anecdotally associated with hepatotoxicity, particularly in persons coinfected with hepatitis C or B virus.Objectives: To ascertain if incidence of severe hepatotoxicity during antiretroviral therapy is similar for all antiretroviral drug combinations, and to define the role of chronic viral hepatitis in its development.Design: Prospective cohort study.Setting: University-based urban HIV clinic.Patients: A total of 298 patients who were prescribed new antiretroviral therapies between January 1996 and January 1998, 211 (71%) of whom received protease inhibitors as part of combination therapy (median follow-up, 182 days) and 87 (29%) of whom received dual nucleoside analog regimens (median follow-up, 167 days). Chronic hepatitis C and B virus infection was present in 154 (52%) and 8 (2.7%) patients, respectively.Main Outcome Measure: Severe hepatotoxicity, defined as a grade 3 or 4 change in levels of serum alanine aminotransferase and aspartate aminotransferase, evaluated before and during therapy.Results: Severe hepatotoxicity was observed in 31 (10.4%) of 298 patients (95% confidence interval [CI], 7.2%-14.4%). Ritonavir use was associated with a higher incidence of toxicity (30%; 95% CI, 17.9% -44.6%). However, no significant difference was detected in hepatotoxicity incidence in other treatment groups, ie, nucleoside analogs (5.7%; 95% CI, 1.2%-12.9%), nelfinavir (5.9%; 95% CI, 1.2%-16.2%), saquinavir (5.9%; 95% CI, 0.15%-28.7%), and indinavir(6.8%; 95% CI, 3.0%-13.1 %). Although chronicviral hepatitis was associated with an increased risk of severe hepatotoxicity among patients prescribed nonritonavir regimens (relative risk, 3.7; 95% CI, 1.0-11.8), most patients with chronic hepatitis C or B virus infection (88%) did not experience significant toxic effects. Rate of severe toxicity with use of any protease inhibitor in patients with hepatitis C infection was 12.2% (13/107; 95% CI, 6.6%-19.9%). In multivariate logistic regression, only ritonavir (adjusted odds ratio [AOR], 8.6; 95% CI, 3.0-24.6) and a CD4 cell count increase of more than 0.05 x 10(9)/L (AOR, 3.6; 95% CI, 1.0-12.9) were associated with severe hepatotoxicity. No irreversible outcomes were seen in patients with severe hepatotoxicity.Conclusions: Our data indicate that use of ritonavir may increase risk of severe hepatotoxicity. Although hepatotoxicity may be more common in persons with chronic viral hepatitis, these data do not support withholding protease inhibitor therapy from persons coinfected with hepatitis B or C virus. [ABSTRACT FROM AUTHOR]- Published
- 2000
- Full Text
- View/download PDF
13. Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?
- Author
-
Cromwell, David M., Bass, Eric B., Cromwell, D M, Bass, E B, Steinberg, E P, Yasui, Y, Ravich, W J, Hendrix, T R, McLeod, S F, and Moore, R D
- Subjects
PEPTIC ulcer ,ULCER treatment ,HEALTH policy ,MEDICAID ,ECONOMIC impact ,MEDICAL care cost statistics ,COMPARATIVE studies ,COST control ,DECISION making ,DRUG utilization ,HOSPITAL care ,GASTROINTESTINAL agents ,MANAGEMENT ,RESEARCH methodology ,MEDICAL cooperation ,REGRESSION analysis ,RESEARCH ,RESEARCH funding ,HEALTH insurance reimbursement ,EVALUATION research ,ECONOMICS ,THERAPEUTICS - Abstract
Objective: To examine the impact of a policy restricting reimbursement for Medicaid anti-ulcer drugs on anti-ulcer drug use and peptic-related hospitalizations.Data Sources/study Setting: In addition to U.S. Census Bureau data, all of the following from Florida: Medicaid anti-ulcer drug claims data, 1989-1993; Medicaid eligibility data, 1989-1993; and acute care nonfederal hospital discharge abstract data (Medicaid and non-Medicaid), 1989-1993.Study Design: In this observational study, a Poisson multiple regression model was used to compare changes, after policy implementation, in Medicaid reimbursement for prescription anti-ulcer drugs as well as hospitalization rates between pre- and post-implementation periods in Medicaid versus non-Medicaid patients hospitalized with peptic ulcer disease.Principal Findings: Following policy implementation, the rate of Medicaid reimbursement for anti-ulcer drugs decreased 33 percent (p < .001). No associated increase occurred in the rate of Medicaid peptic-related hospitalizations.Conclusions: Florida's policy restricting Medicaid reimbursement for anti-ulcer drugs was associated with a substantial reduction in outpatient anti-ulcer drug utilization without any significant increase in the rate of hospitalization for peptic-related conditions. [ABSTRACT FROM AUTHOR]- Published
- 1999
14. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.
- Author
-
Moore, R D, Kessler, H, Richman, D D, Flexner, C, and Chaisson, R E
- Subjects
- *
AIDS complications , *AZIDOTHYMIDINE , *HIV infection complications , *AIDS-related complex , *COMPARATIVE studies , *HIV infections , *LONGITUDINAL method , *LYMPHOMAS , *RESEARCH methodology , *MEDICAL cooperation , *OPPORTUNISTIC infections , *RESEARCH , *EVALUATION research , *PROPORTIONAL hazards models , *CASE-control method , *DISEASE complications ,DRUG therapy for AIDS - Abstract
We wished to determine the incidence of human immunodeficiency virus-related high-grade non-Hodgkin's lymphoma (NHL) and identify factors associated with the development of NHL in patients receiving zidovudine. Data are from a 2-year prospective, observational, multisite study of 1030 patients with the acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex who received zidovudine. Non-Hodgkin's lymphoma developed in 24 (2.3%) of 1030 patients who received zidovudine during 1463 person-years of follow-up (rate, 1.6 per 100 person-years of therapy). The relative hazard for development of NHL was stable throughout 2 years of therapy, with the risk of developing NHL 0.8% for each additional 6 months of therapy. Factors associated with development of NHL were a prior diagnosis of Kaposi's sarcoma, herpes simplex virus infection, or lower mean neutrophil count. Less strongly associated was a prior diagnosis of oral hairy leukoplakia or homosexual transmission of HIV. By Cox proportional hazards analysis, a prior diagnosis of Kaposi's sarcoma, cytomegalovirus disease, or oral hairy leukoplakia was most strongly associated with development of NHL. Our study demonstrates a relatively high incidence of NHL in patients with advanced human immunodeficiency virus disease who are undergoing antiretroviral therapy and suggests possible risk factors for development of NHL. [ABSTRACT FROM AUTHOR]
- Published
- 1991
- Full Text
- View/download PDF
15. Prevalence, detection, and treatment of alcoholism in hospitalized patients.
- Author
-
Moore, R D, Bone, L R, Geller, G, Mamon, J A, Stokes, E J, and Levine, D M
- Subjects
- *
DIAGNOSIS of alcoholism , *ALCOHOLISM treatment , *ALCOHOLISM , *COMPARATIVE studies , *HEALTH facilities , *HOSPITAL care , *RESEARCH methodology , *MEDICAL cooperation , *MEDICAL education , *RESEARCH , *SMOKING , *DEPARTMENTS , *SOCIOECONOMIC factors , *EVALUATION research , *EDUCATIONAL attainment - Abstract
As part of an institution-wide program to enhance the education of physicians in diagnosing and treating alcohol dependence and abuse, a comprehensive survey was conducted in which all new admissions to the adult inpatient services of The Johns Hopkins Hospital were screened for alcoholism. The prevalence of screen-positive alcoholism, by department, was as follows: medicine (25%), psychiatry (30%), neurology (19%), obstetrics-gynecology (12.5%), and surgery (23%). Detection rates by the house staff and faculty physicians caring for those patients who screened positively were less than 25% in surgery and obstetrics-gynecology, between 25% and 50% in neurology and medicine, and greater than 50% in psychiatry. However, physicians were less likely to identify as alcoholic those patients with higher incomes, higher education, or private medical insurance; women; and those who denied heavy alcohol intake. Physician-instituted treatment rates for those patients diagnosed by the physician as having nonrecovered alcoholism were less than 50% in surgery and obstetrics-gynecology, between 50% and 75% in medicine and neurology, and 100% in psychiatry. The extent to which the physicians intervened while the patient was hospitalized correlated with the patient's reported change in alcohol use after discharge. Recommendations based on these data are being incorporated into the medical education curriculum. [ABSTRACT FROM AUTHOR]
- Published
- 1989
- Full Text
- View/download PDF
16. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients.
- Author
-
Maenza, Janine R., Keruly, Jeanne C., Moore, Richard D., Chaisson, Richard E., Merz, William G., Gallant, Joel E., Maenza, J R, Keruly, J C, Moore, R D, Chaisson, R E, Merz, W G, and Gallant, J E
- Subjects
ANTIFUNGAL agents ,CANDIDA ,COMPARATIVE studies ,DRUG resistance in microorganisms ,ESOPHAGUS diseases ,IMMUNOLOGICAL tolerance ,RESEARCH methodology ,MEDICAL cooperation ,MICROBIAL sensitivity tests ,RESEARCH ,RESEARCH funding ,THRUSH (Mouth disease) ,AIDS-related opportunistic infections ,EVALUATION research ,CASE-control method ,FLUCONAZOLE ,CD4 lymphocyte count ,PHARMACODYNAMICS - Abstract
In a case-control study to identify risk factors for fluconazole-resistant oroesophageal candidiasis in human immunodeficiency virus-infected patients, 25 patients with clinical and in vitro fluconazole-resistant candidiasis were paired with controls who had treatment-responsive candidiasis and who had been observed for similar time periods. After their first episode of candidiasis, patients who later developed fluconazole resistance had more treated episodes than did matched controls (cases, 3.1; controls, 1.8; P = .004), lower median CD4 cell counts (11/mm3 vs. 71/mm/3; P = .004), and greater median durations of all antifungal therapy (419 vs. 118 days; P < .001) and of systemic azole therapy (272 vs. 14 days; P < .001). When paired with a second set of controls matched by CD4 cell count as well as first diagnosis of candidiasis, cases continued to show greater median exposure to azoles (272 vs. 88 days; P = .005). These data indicate that advanced immunosuppression and exposure to oral azoles are risk factors for the development of fluconazole resistance. [ABSTRACT FROM AUTHOR]
- Published
- 1996
17. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.
- Author
-
Moore, Richard D., Lietman, Paul S., Smith, Craig R., Moore, R D, Lietman, P S, and Smith, C R
- Subjects
BACTERIAL diseases ,CLINICAL trials ,COMPARATIVE studies ,GENTAMICIN ,GRAM-negative bacteria ,RESEARCH methodology ,MEDICAL cooperation ,MICROBIAL sensitivity tests ,RESEARCH ,STATISTICAL sampling ,EVALUATION research ,TOBRAMYCIN ,BLIND experiment ,AMIKACIN ,PHARMACODYNAMICS ,THERAPEUTICS - Abstract
In an examination of the relationships among plasma aminoglycoside concentrations, the minimal inhibitory concentration (MIC) for the infecting organism, and therapeutic outcome, data were analyzed from 236 patients with gram-negative bacterial infections who were participants in four clinical trials of gentamicin, tobramycin, and amikacin. Clinical response to therapy occurred in 188 (80%) patients. Elevated maximal and mean peak aminoglycoside concentration/MIC ratios were strongly associated with clinical response (P less than .00001 and P less than .0001, respectively). A graded dose-response effect was found between an increasing maximal peak concentration/MIC ratio and clinical response. By logistic regression the peak concentration/MIC ratios were associated significantly with clinical response after adjustment for underlying severity of illness and other factors correlated with response. These results demonstrate that a high peak concentration relative to the MIC for the infecting organism is a major determinant of the clinical response to aminoglycoside therapy. [ABSTRACT FROM AUTHOR]
- Published
- 1987
- Full Text
- View/download PDF
18. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
- Author
-
Moore, Richard D., Smith, Craig R., Lietman, Paul S., Moore, R D, Smith, C R, and Lietman, P S
- Subjects
BODY temperature ,CLINICAL trials ,COMPARATIVE studies ,GENTAMICIN ,HEARING disorders ,RESEARCH methodology ,MEDICAL cooperation ,PROBABILITY theory ,RESEARCH ,SEPSIS ,STATISTICS ,TIME ,TOBRAMYCIN ,EVALUATION research ,RANDOMIZED controlled trials ,RELATIVE medical risk ,KANAMYCIN ,AMIKACIN - Abstract
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides were determined from the analysis of 135 patients enrolled in three prospective, randomized, double-blind clinical trials of gentamicin, tobramycin, and amikacin. Auditory toxicity, defined as a decrease in auditory acuity of greater than or equal to 15 dB, occurred in 30 patients (22.3%). Patients with auditory toxicity underwent therapy for a longer period, were more likely to be bacteremic, and had, on the average, a higher temperature (P less than 0.05). Using stepwise discriminant analysis, we selected these factors with liver dysfunction and the serum urea nitrogen:serum creatinine ratio in a function that accurately discriminates between toxic and nontoxic patients. Factors not adding significantly to the predictive accuracy of the equation were plasma aminoglycoside levels, aminoglycoside type, furosemide use, diabetes, age, sex, renal function, initial auditory acuity, hematocrit value, and shock. This analysis may be important both for determining the pathophysiology of auditory toxicity and for the prognostic stratification of patients receiving aminoglycosides in clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 1984
- Full Text
- View/download PDF
19. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
- Author
-
Easterbrook, P J, Keruly, J C, Creagh-Kirk, T, Richman, D D, Chaisson, R E, and Moore, R D
- Subjects
DRUG therapy for AIDS ,MORTALITY of AIDS patients ,AIDS ,ANEMIA ,AZIDOTHYMIDINE ,BLACK people ,COMPARATIVE studies ,HISPANIC Americans ,HIV infections ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,MULTIVARIATE analysis ,OPPORTUNISTIC infections ,RESEARCH ,EVALUATION research ,TREATMENT effectiveness ,ANTI-HIV agents - Abstract
Unlabelled: OBJECTIVES--To determine if racial-ethnic differences exist in survival, disease progression, and development of myelosuppression in zidovudine-treated patients with advanced human immunodeficiency virus (HIV) disease. DESIGN--Prospective observational study.Setting: -Hospital and private clinics in 12 metropolitan centers.Patients: -The study included 754 non-Hispanic white, 165 black, and 106 Hispanic patients with the acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex (ARC) who received up to 2 years of zidovudine therapy. OUTCOME MEASURES--Survival, development of Pneumocystis carinii pneumonia (PCP), other opportunistic infections, and myelosuppression. RESULTS--At initiation of zidovudine therapy, Hispanic and particularly black patients had more advanced HIV disease than white patients, as indicated by lower baseline CD4+ counts, hematocrits, and AIDS-defining diagnoses. Black patients with AIDS also had a worse prognosis compared with white and Hispanic patients with AIDS. The product-limit survival rates at 2 years for white, black, and Hispanic patients with AIDS were 40%, 27%, and 39%, respectively (black vs white, P = .01; Hispanic vs white, P = .32, by the log-rank test). The respective proportions of patients who developed PCP at 2 years were 46%, 66%, and 44% (black vs white, P = .0001; Hispanic vs white, P = .86) and for other opportunistic infections the proportions were 56%, 63%, and 63%, respectively (black vs white, P = .03; Hispanic vs white, P = .09). There were no significant racial-ethnic differences in survival or in the development of opportunistic infections for patients with ARC, and there were no differences in the incidence of myelosuppression or dose reduction or suspension for patients with either ARC or AIDS. After adjusting for more advanced HIV disease (mainly low CD4+ counts and hematocrits), black race was no longer a significant independent predictor of survival. Adjustment for racial differences in the use of PCP prophylaxis accounted for most of the excess risk for the development of PCP in black patients compared with white patients with AIDS. CONCLUSIONS--Racial differences in survival and the development of opportunistic infections are mainly due to the more advanced HIV disease in black patients when zidovudine therapy is started and to their less frequent use of PCP prophylaxis. Innovative approaches are needed to ensure more widespread use of and earlier access to zidovudine therapy and PCP prophylaxis. [ABSTRACT FROM AUTHOR]- Published
- 1991
- Full Text
- View/download PDF
20. Knowledge, attitudes, and reported practices of medical students and house staff regarding the diagnosis and treatment of alcoholism.
- Author
-
Geller, G, Levine, D M, Mamon, J A, Moore, R D, Bone, L R, and Stokes, E J
- Subjects
DIAGNOSIS of alcoholism ,PSYCHOLOGY of alcoholism ,ALCOHOLISM treatment ,ACADEMIC medical centers ,ATTITUDE (Psychology) ,COMPARATIVE studies ,CURRICULUM ,INTERNSHIP programs ,RESEARCH methodology ,MEDICAL cooperation ,MEDICAL personnel ,PSYCHOLOGY of medical students ,PHYSICIANS ,RESEARCH ,SURVEYS ,OCCUPATIONAL roles ,EVALUATION research - Abstract
Although alcoholism is prevalent in both general and inpatient populations, barriers to its timely diagnosis and effective treatment exist. These are often attributed to physicians' inadequate understanding and skill development and negative attitudes toward the disease. All Johns Hopkins' medical students and house staff, during 1986 through 1987, received a self-administered survey of their attitudes, skills, perceived role responsibility, knowledge, and reported practices with regard to alcoholism. Results indicate a strong relationship between perceived role responsibility, confidence in skills, and reported screening and referral practices among students and house staff. Knowledge levels strengthened the association between skills and practices for medical students. House staff perceived less of a responsibility for screening than medical students. There was a trend toward lower confidence and more negative attitudes among house staff than medical students. The results point to areas where educational interventions can be improved to enhance quality of care and outcomes for this major chronic disease. [ABSTRACT FROM AUTHOR]
- Published
- 1989
- Full Text
- View/download PDF
21. The Cellular Response of the Spleen and its Relationship to the Circulating 19S and 7S Antibody in the Antigenically Stimulated Rabbit*
- Author
-
Schoenberg, M. D., Rupp, J. C., and Moore, R. D.
- Subjects
Diphtheria Toxoid ,Research ,Freund's Adjuvant ,Plasma Cells ,Immunoglobulins ,Articles ,Antibodies ,Basophils ,Mycobacterium ,Antigen-Antibody Reactions ,Antibody Formation ,Animals ,Serum Globulins ,Lymphocytes ,Rabbits ,Spleen - Published
- 1964
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.